Quantcast Clovis Oncology Inc Stock Quote | Stock Price for CLVS | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Clovis Oncology Inc (NQ: CLVS)
23.80 USD  +0.49 (+2.10%)
Streaming Delayed Price  /  Updated: 8:00 AM EST, Jan 16, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 500
Open 22.83
Bid (Size) 22.91 (5)
Ask (Size) 23.80 (4)
Prev. Close 23.31
Today's Range 22.28 - 23.80
52wk Range 11.50 - 65.97
Shares Outstanding 52,548,995
Dividend Yield N/A
Performance
YTD
+22.74%
+22.74%
1 Month
+26.06%
+26.06%
3 Month
-22.04%
-22.04%
6 Month
-48.95%
-48.95%
1 Year
-57.05%
-57.05%
Top News
More News
Detailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Canopy Growth... Read More
from GlobeNewswire News Releases
Clovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2018
Clovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2018 Read More
from Business Wire News Releases
More News
Read More
Clovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
from Business Wire News Releases
Stimulated Development of Orphan Drug Designations for Rare Diseases and Anti-Cancer Drug Candidates Intensifies
from PR Newswire
UPDATE 5-Lilly makes $8 bln bet on drugs for rare cancers with Loxo Oncology buy
category companyNews
from Reuters: Company News
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®? (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer
from Business Wire News Releases
3 Biotech Stocks That Soared This Week: Are They Buys?
category CLVS , INSM , Market News , and 2 more.
from Motley Fool
Implied IYH Analyst Target Price: $218
category ETFs
from ETF Channel
Noteworthy Friday Option Activity: CLVS, ABBV, AAL
category Stocks
from Market News Video
Here's Why Clovis Oncology Rose as Much as 21.9% Today
category Market News , CLVS
from Motley Fool
Clovis Oncology Up 19.4% Since SmarTrend Uptrend Call (CLVS)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.